Suchergebnisse - "Lopinavir"

PubPharm (15)

1

Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients

enthalten in: Therapeutic drug monitoring | 2021

von Chouchana, L. | Boujaafar, S. | Gana, I. | +13

2

Important Interactions of Immunosuppressants With Experimental Therapies for Novel Coronavirus Disease (COVID-19) : How to Act

enthalten in: Therapeutic drug monitoring | 2020

von Zijp, T. | Toren-Wielema, M. | Nannan Panday, P. | +3

CommentOn: N Engl J Med. 2020 May 7;382(19):1787-1799. - PMID 32187464

3

Lopinavir/ritonavir pharmacokinetics, efficacy, and safety in HIV and hepatitis B or C coinfected adults without symptoms of hepatic impairment

enthalten in: Therapeutic drug monitoring | 2014

von Khaykin, P. | Kotzerke, P. | Stephan, C. | +7

4

Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients

enthalten in: Therapeutic drug monitoring | 2011

von López Aspiroz, E. | Santos Buelga, D. | Cabrera Figueroa, S. | +4

5

CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children

enthalten in: Therapeutic drug monitoring | 2011

von Rakhmanina, N. | Neely, M. | Van Schaik, R. | +4

6

Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis

enthalten in: Therapeutic drug monitoring | 2008

von Micheli, V. | Regazzi, M. | Dickinson, L. | +11

7

Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors : validation and application

enthalten in: Therapeutic drug monitoring | 2007

von Keil, K. | Hochreitter, J. | DiFrancesco, R. | +5

8

Limited penetration of lopinavir and ritonavir in the genital tract of men infected with HIV-1 in Brazil

enthalten in: Therapeutic drug monitoring | 2006

von Vergara, T. | Estrela, R. | Suarez-Kurtz, G. | +3

9

No significant influence of saquinavir hard-gel capsule administration on pharmacokinetics of lopinavir in combination with ritonavir : a population approach

enthalten in: Therapeutic drug monitoring | 2005

von Dailly, E. | Gagnieu, M. | Allavena, C. | +2

10

Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography

enthalten in: Therapeutic drug monitoring | 2005

von Poirier, J. | Robidou, P. | Jaillon, P.